A team of scientists from La Trobe University has shown a protein found in a tobacco plant has the potential to fight life-threatening infectious diseases
The scientific discovery, published in the prestigious journal Nature Communications could lead to the development of a new class of antibiotics and meet the challenge of rising antibiotic resistance.
Dr Mark Hulett and Dr Marc Kvansakul from the La Trobe Institute for Molecular Science said their team had demonstrated the peptide NaD1 found in the flowers of the ornamental tobacco plant Nicotiana alata has infection-busting qualities.
“Infectious diseases are a major global health problem, accounting for more than one in eight deaths and mortality rates are predicted to skyrocket over the next 30 years,” Dr Hulett said.
“Antibiotic resistance at the current rate will eventually lead to the exhaustion of effective long-term drug options. It’s imperative we develop new antibiotic treatments.”
Using the power of the Australian Synchrotron, the team led by Dr Hulett and Dr Kvansakul have shown in atomic detail how the tobacco plant peptide can target and destroy the micro-organism responsible for a dangerous fungal infection.
The peptide perforates the parachute-like outer layer of Candida albicans cells, ripping them apart and causing them to explode and die.
“They act in a different way to existing antibiotics and allow us to explore new ways of fighting infections.
“It’s an exciting discovery that could be harnessed to develop a new class of life-saving antimicrobial therapy to treat a range of infectious diseases, including multi-drug-resistant golden staph, and viral infections such as HIV, Zika virus, Dengue and Murray River Encephalitis.”
In 2014, Dr Hulett and Dr Kvansakul found NaD1 could also be effective in killing cancer cells.
Candida albicans is responsible for life-threatening infections in immune-compromised patients, including those diagnosed with cancer and transplant recipients. There are limited effective antibiotics available to treat the infection.
Nicotiana alata flowers naturally produce potent anti-fungal molecules for protection against disease. The plant is related, but different, to tobacco plants grown for commercial use.
Learn more: La Trobe’s infection-busting discovery
The Latest on: Antimicrobial therapy
via Google News
The Latest on: Antimicrobial therapy
- New diagnostic tools are essential in the battle against antibiotic resistanceon October 24, 2019 at 2:06 am
Today, though, with the rise of antimicrobial resistance, we are perilously close to returning to where ... Despite advances in personalized medicine in other areas of health care, using diagnostic ...
- Lifestyle of bacteria determines how they evolve antibiotic resistanceon October 23, 2019 at 6:27 am
How bacteria live -- whether as independent cells or in a communal biofilm -- determines how they evolve antibiotic resistance, which could lead to more personalized approaches to antimicrobial ...
- Bacterial lifestyle alters the evolution of antibiotic resistanceon October 23, 2019 at 12:53 am
How bacteria live—whether as independent cells or in a communal biofilm—determines how they evolve antibiotic resistance, which could lead to more personalized approaches to antimicrobial therapy and ...
- Electronic medical record system may improve efforts to prevent antibiotic drug resistanceon October 17, 2019 at 11:58 am
... documentation system they developed and the continued efforts of the Antimicrobial Stewardship Program have been associated with a 21% decrease in annual antimicrobial days of therapy since 2011.
- New Pneumonia Guidance: Testing, Treating, and Follow-upon October 15, 2019 at 1:06 pm
An updated clinical guideline on pneumonia emphasizes antimicrobial stewardship with recommendations for increased microscopic ... learn more about the epidemiology of what's going on here in the hope ...
- Wireless device that transmits OPAT data to doctors wins $10K prize at IDWeekon October 15, 2019 at 11:25 am
A group of biomedical engineers and medical students calling themselves HIVE developed an innovative solution to help patients and doctors optimize outpatient parenteral antimicrobial therapy, or OPAT ...
- New test assists physicians with quicker treatment decisions for sepsison October 3, 2019 at 1:37 pm
"Randomized Clinical Trial Evaluating Clinical Impact of RAPid Identification and Antimicrobial Susceptibility Testing ... more quickly and place patients on pathogen-directed therapy rather than ...
- A Rapid ATP Bioluminescence-based Test for Detecting Levofloxacin Resistance Starting from Positive Blood Culture Bottleson October 2, 2019 at 2:13 am
Administering appropriate antimicrobial therapy as early as possible is important for rescuing bacteremic patients. Therefore, rapid antimicrobial susceptibility tests in positive blood culture ...
- FDA considers Ebola vaccine, telehealth ‘viable’ option in antimicrobial stewardship — top stories in infectious diseaseon September 24, 2019 at 10:54 am
increased infectious diseases consultations and lowered costs associated with antimicrobial therapy. Read more.
via Bing News